HPIA
GSK icon

Hamilton Point Investment Advisors’s GSK GSK Stock Holding History

Hamilton Point Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-36,586
Closed -$1.63M – 81
2021
Q1 		$1.63M Buy
36,586
+432
+1% +$19.6K 0.47% 57
2020
Q4 		$1.69M Sell
36,154
-26
-0.1% -$1.19K 0.53% 53
2020
Q3 		$1.72M Buy
36,180
+212
+0.6% +$10.6K 0.61% 51
2020
Q2 		$1.85M Buy
35,968
+572
+2% +$29.3K 0.72% 50
2020
Q1 		$1.7M Buy
35,396
+902
+3% +$48.1K 0.79% 50
2019
Q4 		$2.05M Buy
34,494
+278
+0.8% +$15.5K 0.78% 54
2019
Q3 		$1.84M Buy
34,216
+1,280
+4% +$65.8K 0.75% 53
2019
Q2 		$1.67M Buy
32,936
+10
+0% +$502 0.71% 53
2019
Q1 		$1.75M Sell
32,926
-336
-1% -$16.8K 0.78% 53
2018
Q4 		$1.61M Buy
33,262
+704
+2% +$34.7K 0.82% 53
2018
Q3 		$1.66M Buy
32,558
+128
+0.4% +$6.5K 0.77% 53
2018
Q2 		$1.65M Sell
32,430
-36
-0.1% -$1.81K 0.82% 53
2018
Q1 		$1.61M Buy
32,466
+7,232
+29% +$337K 0.82% 53
2017
Q4 		$1.13M Sell
25,234
-4,179
-14% -$193K 0.59% 57
2017
Q3 		$1.51M Buy
29,413
+196
+0.7% +$9.94K 0.82% 53
2017
Q2 		$1.57M Buy
29,217
+24
+0.1% +$1.28K 0.88% 49
2017
Q1 		$1.54M Buy
29,193
+720
+3% +$36.5K 0.88% 53
2016
Q4 		$1.37M Sell
28,473
-1,092
-4% -$53.9K 0.85% 55
2016
Q3 		$1.59M Buy
29,565
+1,120
+4% +$61.4K 1% 54
2016
Q2 		$1.54M Buy
28,445
+1,156
+4% +$60.9K 1.01% 53
2016
Q1 		$1.38M Buy
27,289
+212
+0.8% +$10.6K 0.92% 56
2015
Q4 		$1.37M Buy
27,077
+2,680
+11% +$137K 0.95% 54
2015
Q3 		$1.17M Sell
24,397
-1,623
-6% -$84.5K 0.92% 51
2015
Q2 		$1.35M Buy
26,020
+3,544
+16% +$200K 1.1% 41
2015
Q1 		$1.3M Sell
22,476
-188
-0.8% -$10.8K 1.07% 47
2014
Q4 		$1.21M Buy
22,664
+760
+3% +$42.5K 1.04% 49
2014
Q3 		$1.26M Buy
21,904
+464
+2% +$28.4K 1.17% 43
2014
Q2 		$1.43M Sell
21,440
-92
-0.4% -$6.23K 1.33% 35
2014
Q1 		$1.44M Buy
21,532
+4,664
+28% +$315K 1.34% 36
2013
Q4 		$1.13M Buy
+16,868
New +$1.09M 1.12% 44

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Hamilton Point Investment Advisors's GSK Position: Q2 2021 in Review

Hamilton Point Investment Advisors sold out of GSK (GSK) in Q2 2021, closing a stake of 36,586 shares — an estimated $1.63M sold.

Hamilton Point Investment Advisors first reported a position in GSK in Q4 2013 and held it in 30 quarters. The position peaked at $2.05M in Q4 2019. 798 funds tracked by Wall St. Rank hold GSK as of Q2 2021.

  • Hamilton Point Investment Advisors reported no remaining GSK position as of Q2 2021 after selling out during the quarter.
  • Hamilton Point Investment Advisors sold 36,586 GSK shares in Q2 2021, an estimated $1.63M.
  • Hamilton Point Investment Advisors first reported a position in GSK in Q4 2013 and held it in 30 quarters.
  • Hamilton Point Investment Advisors's GSK position peaked at $2.05M in Q4 2019.
  • 798 funds tracked by Wall St. Rank held GSK as of Q2 2021.

Based on Hamilton Point Investment Advisors's 13F filing for Q2 2021, filed 2 Aug 2021.